Guardian Pharmacy Services (NYSE:GRDN) Hits New 1-Year High – Here’s What Happened

Guardian Pharmacy Services, Inc. (NYSE:GRDN)’s share price hit a new 52-week high on Monday . The stock traded as high as $37.63 and last traded at $37.90, with a volume of 261565 shares trading hands. The stock had previously closed at $35.62.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on GRDN. Truist Financial lifted their target price on Guardian Pharmacy Services from $34.00 to $38.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. Zacks Research raised shares of Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 18th. Raymond James Financial restated an “outperform” rating and set a $40.00 price objective on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. UBS Group reiterated a “buy” rating on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. Finally, Stephens increased their target price on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the company an “overweight” rating in a research note on Wednesday, January 14th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $38.00.

Guardian Pharmacy Services Trading Up 5.2%

The stock has a fifty day moving average of $32.25 and a 200-day moving average of $29.70. The firm has a market capitalization of $2.37 billion, a price-to-earnings ratio of 48.65 and a beta of 0.85.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Wednesday, March 11th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.27 by $0.10. Guardian Pharmacy Services had a return on equity of 31.64% and a net margin of 3.40%.The business had revenue of $397.62 million during the quarter, compared to the consensus estimate of $390.04 million. Guardian Pharmacy Services’s quarterly revenue was up 17.4% on a year-over-year basis. As a group, equities research analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Institutional Trading of Guardian Pharmacy Services

A number of hedge funds have recently bought and sold shares of the company. Dynamic Technology Lab Private Ltd purchased a new stake in Guardian Pharmacy Services in the 1st quarter worth about $233,000. Envestnet Asset Management Inc. grew its stake in Guardian Pharmacy Services by 7.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after acquiring an additional 805 shares in the last quarter. Geode Capital Management LLC grew its stake in Guardian Pharmacy Services by 65.9% during the 2nd quarter. Geode Capital Management LLC now owns 336,701 shares of the company’s stock valued at $7,177,000 after acquiring an additional 133,715 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its holdings in shares of Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock valued at $52,000 after purchasing an additional 1,062 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Guardian Pharmacy Services in the 2nd quarter valued at about $346,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.